+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Myopia & Presbyopia Treatment Market - Global Forecast 2026-2032- Product Image
Myopia & Presbyopia Treatment Market - Global Forecast 2026-2032- Product Image
New

Myopia & Presbyopia Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5012905
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Myopia & Presbyopia Treatment Market is entering a pivotal phase, driven by clinical innovation, evolving patient preferences, and increasingly complex supply and distribution networks. Senior executives face strategic decisions as advancements in diagnostics and therapies reshape both competitive dynamics and growth potential.

Market Snapshot: Myopia & Presbyopia Treatment Market Overview

The Myopia & Presbyopia Treatment Market expanded from USD 18.64 billion in 2025 to USD 19.82 billion in 2026, with continued growth projected at a CAGR of 6.84%, reaching USD 29.64 billion by 2032. This momentum reflects accelerating adoption of advanced refractive care therapies, an expanding global patient base, and rising demand across diverse age groups.

Scope & Segmentation

  • Treatment Modalities: Includes cataract surgery, corrective lenses (eyeglasses, contact lenses, multifocal lenses, orthokeratology), implantable lenses, and refined surgical interventions.
  • Demographic Segments: Covers pediatric patients, adults, middle-aged, and older adults—with targeted approaches for each cohort to address evolving vision needs and lifestyle demands.
  • Disease Pathways: Encompasses both myopia and presbyopia, with myopia interventions focusing on long-term progression control, and presbyopia solutions prioritizing rapid functional improvement and reduced reliance on corrective wear.
  • Distribution Channels: Spans offline channels such as hospitals, specialty clinics, and optical stores, as well as online models emphasizing convenience, subscription services, and direct-to-patient engagement.
  • Regional Landscape: Examines differentiated regulatory, reimbursement, and market entry strategies across North America, Europe, the Middle East & Africa, and Asia-Pacific, recognizing unique distribution and provider ecosystems in each region.
  • Technologies: Features advancements in diagnostic imaging, biometric analytics, lens materials, multifocal and implantable lens design, and digital health platforms including tele-optometry and hybrid care models.

Key Takeaways for Decision-Makers

  • Clinical advances are supporting more individualized treatment planning and outcome tracking, enabling providers and manufacturers to better address patient needs and expectations.
  • Demographic shifts are amplifying the demand for vision correction interventions at both ends of the age spectrum, driving innovation in pediatric myopia control and presbyopia management for aging populations.
  • Successful market execution requires integrating supply chain flexibility with diversified manufacturing and supplier networks to manage operational risk and ensure timely product availability.
  • Stakeholders must align regulatory and reimbursement strategies with ongoing clinical evidence generation, as real-world outcomes and quality-of-life measurements become decisive adoption criteria.
  • Multi-stakeholder engagement, including strategic alliances between device manufacturers and optical retailers, is accelerating the creation of integrated care pathways and seamless patient journeys.
  • Channel optimization—combining high-touch offline care with scalable online services—enables tailored solutions for varying patient preferences and local market requirements.

Tariff Impact: Navigating Policy and Supply Chain Dynamics

Recent trade policy adjustments and new tariff structures are influencing sourcing strategies across the vision care sector. Increases in import duties and compliance demands have prompted manufacturers to diversify suppliers, expand local assembly, and consider regional manufacturing hubs. Distribution and clinical providers are adapting inventory and contractual approaches to manage price volatility and ensure supply chain resilience. Strategic partnership with local entities has become a cornerstone for mitigating disruption and supporting long-term regional market entry and compliance.

Myopia & Presbyopia Treatment Market: Methodology & Data Sources

This report synthesizes data from peer-reviewed clinical research, stakeholder interviews, regulatory documentation, and supply chain analyses. Both qualitative and quantitative inputs inform the segmentation, technology assessment, and market risk evaluation, ensuring findings are grounded in practical insights drawn from diverse industry perspectives and independent research streams.

Why This Report Matters

  • Actionable, segment-specific insights enable senior leaders to prioritize investments based on regional growth patterns and competitive positioning.
  • Evidence-based analysis supports more informed strategic decisions around R&D, commercial model evolution, and supplier diversification in a volatile policy landscape.
  • The report delivers practical frameworks for aligning clinical innovation with procurement, regulatory, and distribution strategies to unlock new opportunities in refractive care markets.

Conclusion

Aligning clinical validation, operational adaptability, and channel excellence is essential for sustainable growth in the refractive care market. Organizations positioned for success will convert technological and commercial capability into measurable market traction and enduring value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Myopia & Presbyopia Treatment Market, by Treatment Type
8.1. Cataract Surgery
8.2. Corrective Lenses
8.2.1. Contact Lenses
8.2.2. Eyeglasses
8.2.3. Multifocal Lenses
8.2.4. Orthokeratology Lenses
8.3. Implantable Lenses
8.4. Surgical Treatments
9. Myopia & Presbyopia Treatment Market, by Age Group
9.1. Adults
9.2. Middle-aged
9.3. Older Adults
9.4. Pediatric
10. Myopia & Presbyopia Treatment Market, by Disease Type
10.1. Myopia Treatment
10.2. Presbyopia Treatment
11. Myopia & Presbyopia Treatment Market, by Distribution Channel
11.1. Offline
11.1.1. Hospitals
11.1.2. Optical Stores
11.1.3. Specialty Clinics
11.2. Online
12. Myopia & Presbyopia Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Myopia & Presbyopia Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Myopia & Presbyopia Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Myopia & Presbyopia Treatment Market
16. China Myopia & Presbyopia Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. ABB Optical Group
17.6. AbbVie Inc.
17.7. AccuLens
17.8. Alcon Inc.
17.9. ARCTIC VISION HONG KONG BIOTECH LIMITED
17.10. Bausch & Lomb Incorporated.
17.11. Carl Zeiss AG
17.12. EssilorLuxottica
17.13. Euclid Systems Corporation
17.14. Eyenovia, Inc.
17.15. Haag-Streit Group
17.16. HOYA Vision Care Europe Hoya Holdings N.V.
17.17. Johnson & Johnson Vision Care, Inc.
17.18. LENZ Therapeutics, Inc.
17.19. Menicon Co., Ltd.
17.20. NIDEK CO., LTD.
17.21. Orasis Pharmaceuticals, Ltd
17.22. Regeneron Pharmaceuticals Inc.
17.23. SCHWIND eye-tech-solutions GmbH?
17.24. Sydnexis, Inc.
17.25. The Cooper Companies Inc.
17.26. Topcon Corporation
17.27. Ziemer Ophthalmic Systems AG
List of Figures
FIGURE 1. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY EYEGLASSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY EYEGLASSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY EYEGLASSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MULTIFOCAL LENSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MULTIFOCAL LENSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MULTIFOCAL LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ORTHOKERATOLOGY LENSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ORTHOKERATOLOGY LENSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ORTHOKERATOLOGY LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY IMPLANTABLE LENSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY IMPLANTABLE LENSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY IMPLANTABLE LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MIDDLE-AGED, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MIDDLE-AGED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MIDDLE-AGED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OLDER ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OLDER ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OPTICAL STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OPTICAL STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OPTICAL STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 97. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 98. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 108. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 111. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 112. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 113. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 126. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 127. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. ASEAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 130. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 132. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 133. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 134. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 135. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. GCC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 144. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 146. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 147. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 148. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 149. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. BRICS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 151. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 153. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 154. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 155. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 156. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. G7 MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 158. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 160. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 161. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 162. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. NATO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 173. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 174. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 175. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CORRECTIVE LENSES, 2018-2032 (USD MILLION)
TABLE 176. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 178. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Myopia & Presbyopia Treatment market report include:
  • ABB Optical Group
  • AbbVie Inc.
  • AccuLens
  • Alcon Inc.
  • ARCTIC VISION HONG KONG BIOTECH LIMITED
  • Bausch & Lomb Incorporated.
  • Carl Zeiss AG
  • EssilorLuxottica
  • Euclid Systems Corporation
  • Eyenovia, Inc.
  • Haag-Streit Group
  • HOYA Vision Care Europe Hoya Holdings N.V.
  • Johnson & Johnson Vision Care, Inc.
  • LENZ Therapeutics, Inc.
  • Menicon Co., Ltd.
  • NIDEK CO., LTD.
  • Orasis Pharmaceuticals, Ltd
  • Regeneron Pharmaceuticals Inc.
  • SCHWIND eye-tech-solutions GmbH​
  • Sydnexis, Inc.
  • The Cooper Companies Inc.
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 19.82 Billion
Forecasted Market Value ( USD ) by 2032 $ 29.64 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Myopia and Presbyopia Treatment Market Report 2025 - Product Image

Myopia and Presbyopia Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Myopia and Presbyopia Treatment - Global Strategic Business Report - Product Image

Myopia and Presbyopia Treatment - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Myopia Treatment Devices Market Report and Forecast 2025-2034 - Product Image

Myopia Treatment Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Myopia Treatment Devices Market Report 2025 - Product Image

Myopia Treatment Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Myopia and Presbyopia Eye Drop Market - Global Forecast 2025-2030 - Product Image

Myopia and Presbyopia Eye Drop Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.